Embody programs and current prices
2 comparison programs and 1 additional listings, checked 29 August 2026.
| Treatment | Current monthly price | Format | Visit |
|---|---|---|---|
 Semaglutide | $79a month, continuing | Weekly subcutaneous injection | Visit |
 Tirzepatide | $129a month, continuing | Weekly subcutaneous injection | Visit |
| Sexual health | |||
 Rodeo ED treatment | $99 / 6 doses or $119 / 12 doses | Clinician-selected compounded oral doses | Visit |
Verdict: strongest for price-focused buyers who verify the plan first
Embody is most compelling for a cash-pay reader who wants compounded injectable GLP-1 care, medication and shipping in one published program price, and more pharmacy transparency than many telehealth storefronts provide. It is not the best fit for someone who expects the smallest headline to mean a flexible monthly commitment. The catalog shows separate continuing and prepaid bases, and the terms deserve attention before a card is charged.
Our verdict is cautiously favorable on catalog clarity and cautious on operations. Embody identifies its administrative operator, clinical network, and possible dispensing pharmacies. Against that, current BBB and Trustpilot records show material service and complaint signals. A reader should confirm the full charge, plan length, renewal cadence, cancellation deadline, and assigned pharmacy in writing before enrolling.
Compare the continuing rate, not only the prepaid headline
Embody has canonical medication-included offers for compounded semaglutide and compounded tirzepatide. The live comparison uses the catalog's continuing price as its main basis and labels the lower effective rate only when a longer prepaid commitment produces it.
- Semaglutide$79 monthly · $69 effective monthly on the 12-month plan
- Tirzepatide$129 monthly · $119 effective monthly on the 12-month plan
Both rows include medication when prescribed, clinician review, supplies, standard shipping, and support according to Embody's product materials. They remain compounded products rather than FDA-approved branded drugs. Confirm the total collected today and the exact term because the smallest effective figure is not automatically a cancel-anytime monthly rate.
The service is split across three sets of companies
Modern Metabolic Medicine, Inc. operates the Embody platform. Embody's terms name OpenLoop Health as the clinical provider, so OpenLoop clinicians, not the storefront, make prescribing decisions. Embody also states that it is not a pharmacy.
The checked privacy and terms materials name Red Rock Pharmacy, Health Warehouse, Precision Compounding Pharmacy, and Triad Rx as possible partners. That is useful disclosure, but it does not tell a patient which pharmacy will fill a particular prescription. Verify the name on the prescription or vial and check that pharmacy's license in the patient's state.
Cancellation becomes harder after fulfillment begins
Embody's refund policy requires advance notice before billing and narrows refund eligibility once medication has been ordered. A patient who is medically disqualified is described as eligible for a full refund, while processed prescription orders face a different boundary.
This timing matters because a support request is not the same thing as a completed cancellation. Save the selected plan, order confirmation, next billing date, and written cancellation response. Do not assume that an unused prescription can be returned after a pharmacy has prepared or shipped it.
Independent profiles make support reliability the main concern
The current BBB profile connects Embody to Modern Metabolic Medicine and assigns the operator an F rating, citing unresolved complaints. Trustpilot's joined Embody profile is materially more positive overall but also contains a substantial negative share and says that the company asks customers for reviews. Neither platform measures clinical quality or medication potency.
Read those records as operational signals, not a vote on whether a prescription will work. The repeated questions worth carrying into checkout concern communication, fulfillment timing, cancellation, and unexpected charges. Individual reports remain allegations or personal experiences unless supported by a regulator or a first-party record.
Alternatives depend on what you are trying to avoid
A buyer who dislikes prepayment should compare true month-to-month compounded programs. Someone who wants an FDA-approved product should compare branded semaglutide or tirzepatide access and keep insurance, savings-card, and medication costs separate. A patient who values a longer lab-led relationship may prefer a membership model even when its headline cost is higher.
Embody's distinct advantage is a simple, medication-included GLP-1 catalog with named partners. Its distinct weakness is the gap between that clean product presentation and the operational risk visible in independent complaint records. The right decision turns on the written plan terms, not the advertisement alone.
Get five answers in writing before payment
First, ask whether the selected figure is a continuing monthly charge, an effective monthly calculation on a prepaid total, or a promotion. Second, ask how much will be collected immediately. Third, identify the date and amount of the next charge. Fourth, request the cancellation method and the deadline that controls the next renewal. Fifth, ask which pharmacy is expected to fill the prescription in the patient's state. These answers turn a polished offer into a contract a buyer can actually evaluate.
The medical side needs its own confirmation. The prescriber should know the patient's medications, contraindications, relevant history, and treatment goals before deciding whether to prescribe. The patient should receive the formulation, concentration, storage instructions, supplies, and contact route for adverse effects from the responsible clinical or pharmacy party. Embody's website can describe a program, but it cannot replace the prescription label or a patient-specific discussion with the licensed clinician responsible for care. If support cannot answer the commercial questions before payment, that is a reason to pause rather than assume the most favorable interpretation.
How this review was prepared
We checked Embody’s public pricing and programme pages on 29 August 2026. The review covers published pricing, plan terms, inclusions, and availability. It is not a rating, a clinical assessment, or a guarantee of eligibility or outcomes.
- Embody terms and clinical parties
- Embody cancellation and refund policy
- Embody compounded semaglutide product page
- Embody compounded tirzepatide product page
- BBB profile for Modern Metabolic Medicine
- Trustpilot profile for joinem.co
Evidence limits
- The BBB rating and consumer-review distribution are dated snapshots and can change.
- Consumer platforms do not establish clinical quality, medication identity, or representative outcomes.
- Louisiana is excluded for weight management, and Nebraska applies a higher age threshold in the checked provider materials.